BOLAGSKÄLLOR

BridgeBio Pharma, Inc.

Statiskt källarkiv med kurshistorik, finansiella rapporter och regulatoriska dokument. För nordiska bolag används Nasdaq Nordic primärt och MFN endast för saknade rapportperioder.

Slug: bridgebio-pharma-inc Dokument: 18 Status: complete
Nasdaq marknadsdataretrieved2026-08-05: stängning 81.99, volym 2424588
Finansiella rapporter 0 0 Nasdaq primär · 0 MFN fallback
SEC EDGARretrieved88 arkiverade filings

Källidentiteter

Kontrollera dessa identiteter innan data används i en värdering.

Visa verifierad/resolverad metadata
{
  "finansinspektionen": null,
  "mfn": null,
  "nasdaq": null,
  "nasdaq_reports": null,
  "sec": {
    "cik": "0001743881",
    "expected_name": "BridgeBio Pharma, Inc.",
    "match_score": 100.0,
    "method": "explicit_ticker",
    "status": "resolved",
    "ticker": "BBIO",
    "title": "BridgeBio Pharma, Inc."
  }
}

Snabblänkar för ChatGPT och andra läsare

Bolagets llms.txt · company.json · documents.json · reports.json

Nasdaq kurshistorik CSV · Nasdaq kurshistorik JSON · Nasdaq manifest JSON · SEC Company Facts JSON · SEC filing-manifest JSON · SEC sammanfattning JSON

SEC Company Facts – strukturerade nyckeltal

Värdena kommer direkt från emittentens XBRL-facts. Samma begrepp kan ändra definition mellan perioder; läs alltid den officiella filing-texten.

Intäkter – us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
PeriodFormVärdeEnhetInlämnad
2026-03-3110-Q194515000USD2026-05-07
2025-03-3110-Q116633000USD2026-05-07
2025-12-3110-K502076000USD2026-02-24
2024-12-3110-K221902000USD2026-02-24
2023-12-3110-K9303000USD2026-02-24
2025-09-3010-Q347898000USD2025-10-29
2024-09-3010-Q216020000USD2025-10-29
2025-06-3010-Q227198000USD2025-08-05
2024-06-3010-Q213288000USD2025-08-05
2025-03-3110-Q116633000USD2025-04-29
2024-03-3110-Q211120000USD2025-04-29
2024-12-3110-K221902000USD2025-02-20
2023-12-3110-K9303000USD2025-02-20
2022-12-3110-K77648000USD2025-02-20
2024-09-3010-Q216020000USD2024-11-12
2023-09-3010-Q7558000USD2024-11-12
Rörelseresultat – us-gaap:OperatingIncomeLoss
PeriodFormVärdeEnhetInlämnad
2026-03-3110-Q-105956000USD2026-05-07
2025-03-3110-Q-104372000USD2026-05-07
2025-12-3110-K-523411000USD2026-02-24
2024-12-3110-K-592973000USD2026-02-24
2023-12-3110-K-607370000USD2026-02-24
2025-09-3010-Q-383849000USD2025-10-29
2024-09-3010-Q-366946000USD2025-10-29
2025-06-3010-Q-238650000USD2025-08-05
2024-06-3010-Q-175196000USD2025-08-05
2025-03-3110-Q-104372000USD2025-04-29
2024-03-3110-Q343000USD2025-04-29
2024-12-3110-K-592973000USD2025-02-20
2023-12-3110-K-607370000USD2025-02-20
2022-12-3110-K-512202000USD2025-02-20
2024-09-3010-Q-366946000USD2024-11-12
2023-09-3010-Q-429954000USD2024-11-12
Nettoresultat – us-gaap:NetIncomeLoss
PeriodFormVärdeEnhetInlämnad
2019-06-3010-Q-69000USD2019-08-14
Resultat per aktie, utspätt – us-gaap:EarningsPerShareDiluted
PeriodFormVärdeEnhetInlämnad
2026-03-3110-Q-0.84USD/shares2026-05-07
2025-03-3110-Q-0.88USD/shares2026-05-07
2025-12-3110-K-3.78USD/shares2026-02-24
2024-12-3110-K-2.88USD/shares2026-02-24
2023-12-3110-K-3.95USD/shares2026-02-24
2025-09-3010-Q-2.79USD/shares2025-10-29
2024-09-3010-Q-1.46USD/shares2025-10-29
2025-06-3010-Q-1.84USD/shares2025-08-05
2024-06-3010-Q-0.59USD/shares2025-08-05
2025-03-3110-Q-0.88USD/shares2025-04-29
2024-03-3110-Q-0.2USD/shares2025-04-29
2024-12-3110-K-2.88USD/shares2025-02-20
2023-12-3110-K-3.95USD/shares2025-02-20
2022-12-3110-K-3.26USD/shares2025-02-20
2024-09-3010-Q-1.46USD/shares2024-11-12
2023-09-3010-Q-2.99USD/shares2024-11-12
Kassa – us-gaap:CashAndCashEquivalentsAtCarryingValue
PeriodFormVärdeEnhetInlämnad
2026-03-3110-Q879891000USD2026-05-07
2025-12-3110-Q570119000USD2026-05-07
2025-03-3110-Q540599000USD2026-05-07
2025-12-3110-K570119000USD2026-02-24
2024-12-3110-K681101000USD2026-02-24
2023-12-3110-K375935000USD2026-02-24
2025-09-3010-Q642951000USD2025-10-29
2024-12-3110-Q681101000USD2025-10-29
2024-09-3010-Q266324000USD2025-10-29
2025-06-3010-Q748953000USD2025-08-05
2024-12-3110-Q681101000USD2025-08-05
2024-06-3010-Q407958000USD2025-08-05
2025-03-3110-Q540599000USD2025-04-29
2024-12-3110-Q681101000USD2025-04-29
2024-03-3110-Q475222000USD2025-04-29
2024-12-3110-K681101000USD2025-02-20
Tillgångar – us-gaap:Assets
PeriodFormVärdeEnhetInlämnad
2026-03-3110-Q1370981000USD2026-05-07
2025-12-3110-Q936025000USD2026-05-07
2025-12-3110-K936025000USD2026-02-24
2024-12-3110-K919338000USD2026-02-24
2025-09-3010-Q998250000USD2025-10-29
2024-12-3110-Q919338000USD2025-10-29
2025-06-3010-Q1080190000USD2025-08-05
2024-12-3110-Q919338000USD2025-08-05
2025-03-3110-Q881638000USD2025-04-29
2024-12-3110-Q919338000USD2025-04-29
2024-12-3110-K919338000USD2025-02-20
2023-12-3110-K546380000USD2025-02-20
2024-09-3010-Q664977000USD2024-11-12
2023-12-3110-Q546380000USD2024-11-12
2024-06-3010-Q794375000USD2024-08-01
2023-12-3110-Q546380000USD2024-08-01
Skulder – us-gaap:Liabilities
PeriodFormVärdeEnhetInlämnad
2026-03-3110-Q3639856000USD2026-05-07
2025-12-3110-Q3012606000USD2026-05-07
2025-12-3110-K3012606000USD2026-02-24
2024-12-3110-K2376950000USD2026-02-24
2025-09-3010-Q2920979000USD2025-10-29
2024-12-3110-Q2376950000USD2025-10-29
2025-06-3010-Q2858609000USD2025-08-05
2024-12-3110-Q2376950000USD2025-08-05
2025-03-3110-Q2520303000USD2025-04-29
2024-12-3110-Q2376950000USD2025-04-29
2024-12-3110-K2376950000USD2025-02-20
2023-12-3110-K1888915000USD2025-02-20
2024-09-3010-Q1883369000USD2024-11-12
2023-12-3110-Q1888915000USD2024-11-12
2024-06-3010-Q1876468000USD2024-08-01
2023-12-3110-Q1888915000USD2024-08-01
Eget kapital – us-gaap:StockholdersEquity
PeriodFormVärdeEnhetInlämnad
2026-03-3110-Q-2278363000USD2026-05-07
2025-12-3110-Q-2086610000USD2026-05-07
2025-12-3110-K-2086610000USD2026-02-24
2024-12-3110-K-1467904000USD2026-02-24
2025-09-3010-Q-1933070000USD2025-10-29
2024-12-3110-Q-1467904000USD2025-10-29
2025-06-3010-Q-1787860000USD2025-08-05
2024-12-3110-Q-1467904000USD2025-08-05
2025-03-3110-Q-1648395000USD2025-04-29
2024-12-3110-Q-1467904000USD2025-04-29
2024-12-3110-K-1467904000USD2025-02-20
2023-12-3110-K-1354257000USD2025-02-20
2024-09-3010-Q-1229922000USD2024-11-12
2023-12-3110-Q-1354257000USD2024-11-12
2024-06-3010-Q-1092925000USD2024-08-01
2023-12-3110-Q-1354257000USD2024-08-01
Operativt kassaflöde – us-gaap:NetCashProvidedByUsedInOperatingActivities
PeriodFormVärdeEnhetInlämnad
2026-03-3110-Q-197279000USD2026-05-07
2025-03-3110-Q-199235000USD2026-05-07
2025-12-3110-K-445910000USD2026-02-24
2024-12-3110-K-520726000USD2026-02-24
2023-12-3110-K-527720000USD2026-02-24
2025-09-3010-Q-389490000USD2025-10-29
2024-09-3010-Q-325400000USD2025-10-29
2025-06-3010-Q-279916000USD2025-08-05
2024-06-3010-Q-144834000USD2025-08-05
2025-03-3110-Q-199235000USD2025-04-29
2024-03-3110-Q-219537000USD2025-04-29
2024-12-3110-K-520726000USD2025-02-20
2023-12-3110-K-527720000USD2025-02-20
2022-12-3110-K-419494000USD2025-02-20
2024-09-3010-Q-325400000USD2024-11-12
2023-09-3010-Q-402901000USD2024-11-12
Investeringar – us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
PeriodFormVärdeEnhetInlämnad
2026-03-3110-Q69000USD2026-05-07
2025-03-3110-Q0USD2026-05-07
2025-12-3110-K1097000USD2026-02-24
2024-12-3110-K933000USD2026-02-24
2023-12-3110-K1306000USD2026-02-24
2025-09-3010-Q1064000USD2025-10-29
2024-09-3010-Q886000USD2025-10-29
2025-06-3010-Q594000USD2025-08-05
2024-06-3010-Q749000USD2025-08-05
2025-03-3110-Q0USD2025-04-29
2024-03-3110-Q695000USD2025-04-29
2024-12-3110-K933000USD2025-02-20
2023-12-3110-K1306000USD2025-02-20
2022-12-3110-K4821000USD2025-02-20
2024-09-3010-Q886000USD2024-11-12
2023-09-3010-Q871000USD2024-11-12
Antal aktier, utspätt – us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
PeriodFormVärdeEnhetInlämnad
2026-03-3110-Q194789897shares2026-05-07
2025-03-3110-Q190145253shares2026-05-07
2025-12-3110-K191527482shares2026-02-24
2024-12-3110-K186075873shares2026-02-24
2023-12-3110-K162791511shares2026-02-24
2025-09-3010-Q190845133shares2025-10-29
2024-09-3010-Q184947173shares2025-10-29
2025-06-3010-Q190332261shares2025-08-05
2024-06-3010-Q183145995shares2025-08-05
2025-03-3110-Q190145253shares2025-04-29
2024-03-3110-Q178705310shares2025-04-29
2024-12-3110-K186075873shares2025-02-20
2023-12-3110-K162791511shares2025-02-20
2022-12-3110-K147473076shares2025-02-20
2024-09-3010-Q184947173shares2024-11-12
2023-09-3010-Q158891152shares2024-11-12

Dokument i fulltext